Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Marsh

Showing results (571-580 of 654) with videos related to

Pageof 66
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 14, 2005
Identification of aminopiperidine benzamides as MCHr1 antagonistsAnil Vasudevan, Mary K Verzal, Derek Wodka, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2003
Central mechanisms regulating penile erection in conscious rats: the dopaminergic systems related to the proerectile effect of apomorphineGin C Hsieh, Peter R Hollingsworth, Brenda Martino, et al.
Bioorganic & Medicinal Chemistry Letters|May 12, 2010
Discovery of TRPV1 antagonist ABT-116Brian S Brown, Ryan Keddy, Richard J Perner, et al.
Journal of Computer-Aided Molecular Design|April 29, 2006
Discovering new classes of Brugia malayi asparaginyl-tRNA synthetase inhibitors and relating specificity to conformational changeSai Chetan K Sukuru, Thibaut Crepin, Youli Milev, et al.
Bioorganic & Medicinal Chemistry Letters|July 24, 2013
Synthesis and SAR of 4-aminocyclopentapyrrolidines as orally active N-type calcium channel inhibitors for inflammatory and neuropathic painXenia Beebe, Clinton M Yeung, Daria Darczak, et al.
Cancer Immunology, Immunotherapy : CII|November 2, 2018
Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapyLaura A Vitale, Lawrence J Thomas, Li-Zhen He, et al.
Journal of Medicinal Chemistry|October 5, 2001
Selective inhibition of ICAM-1 and E-selectin expression in human endothelial cells. 2. Aryl modifications of 4-(aryloxy)thieno[2,3-c]pyridines with fine-tuning at C-2 carbamidesG D Zhu, D L Arendsen, I W Gunawardana, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2006
Correlation between brain/plasma ratios and efficacy in neuropathic pain models of selective metabotropic glutamate receptor 1 antagonistsGuo Zhu Zheng, Pramila Bhatia, Teodozyj Kolasa, et al.
Journal of Medicinal Chemistry|May 8, 2009
Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptorRamin Faghih, Sujatha M Gopalakrishnan, Jens Halvard Gronlien, et al.
Cancer Immunology, Immunotherapy : CII|May 27, 2020
Development of CDX-527: a bispecific antibody combining PD-1 blockade and CD27 costimulation for cancer immunotherapyLaura A Vitale, Li-Zhen He, Lawrence J Thomas, et al.
Pageof 66

Showing results (571-580 of 654) with videos related to

Sort By:
Pageof 66
Bioorganic & Medicinal Chemistry Letters|June 14, 2005
Identification of aminopiperidine benzamides as MCHr1 antagonistsAnil Vasudevan, Mary K Verzal, Derek Wodka, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2003
Central mechanisms regulating penile erection in conscious rats: the dopaminergic systems related to the proerectile effect of apomorphineGin C Hsieh, Peter R Hollingsworth, Brenda Martino, et al.
Bioorganic & Medicinal Chemistry Letters|May 12, 2010
Discovery of TRPV1 antagonist ABT-116Brian S Brown, Ryan Keddy, Richard J Perner, et al.
Journal of Computer-Aided Molecular Design|April 29, 2006
Discovering new classes of Brugia malayi asparaginyl-tRNA synthetase inhibitors and relating specificity to conformational changeSai Chetan K Sukuru, Thibaut Crepin, Youli Milev, et al.
Bioorganic & Medicinal Chemistry Letters|July 24, 2013
Synthesis and SAR of 4-aminocyclopentapyrrolidines as orally active N-type calcium channel inhibitors for inflammatory and neuropathic painXenia Beebe, Clinton M Yeung, Daria Darczak, et al.
Cancer Immunology, Immunotherapy : CII|November 2, 2018
Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapyLaura A Vitale, Lawrence J Thomas, Li-Zhen He, et al.
Journal of Medicinal Chemistry|October 5, 2001
Selective inhibition of ICAM-1 and E-selectin expression in human endothelial cells. 2. Aryl modifications of 4-(aryloxy)thieno[2,3-c]pyridines with fine-tuning at C-2 carbamidesG D Zhu, D L Arendsen, I W Gunawardana, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2006
Correlation between brain/plasma ratios and efficacy in neuropathic pain models of selective metabotropic glutamate receptor 1 antagonistsGuo Zhu Zheng, Pramila Bhatia, Teodozyj Kolasa, et al.
Journal of Medicinal Chemistry|May 8, 2009
Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptorRamin Faghih, Sujatha M Gopalakrishnan, Jens Halvard Gronlien, et al.
Cancer Immunology, Immunotherapy : CII|May 27, 2020
Development of CDX-527: a bispecific antibody combining PD-1 blockade and CD27 costimulation for cancer immunotherapyLaura A Vitale, Li-Zhen He, Lawrence J Thomas, et al.
Pageof 66